Notably, ALDH1A1 has been abundantly expressed in early colon cancer [38], and in breast cancer, it reduces the pH value in tumor cells, activating the inflammatory signal NF-κB, resulting in myeloid cell suppression and immune suppression [16]. Here, NFKB1 is linked to colonic neoplasm.